SEC Form 4 · accession 0001635088-26-000077
Roivant Sciences Ltd. · ROIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Torti
Officer — President and Vant Chair
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 7:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001635088
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 30, 2026 | F | 40,310 | $35.39 | D | 13,536,202 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.